New findings presented at the 2009 annual meeting of the American Society for Nutrition, Experimental Biology, show that an omega-3 fatty acid in the diet protects brain cells by preventing the misfolding of a protein caused by a gene mutation, a process implicated in neurodegenerative diseases like Parkinson's and Huntington's.
A team led by Nicolas Bazan, director of the Neuroscience Center of Excellence at LSU Health Sciences Center New Orleans, USA, developed a cell model with a mutation of the Ataxin-1 gene that results in mis-shaped proteins that cannot be properly processed by the cell machinery, leading to tangled clumps of toxic protein that eventually kill the cell. Spinocerebellar ataxia, a disabling disorder that affects speech and coordination, is caused by an Ataxin-1 misfolding defect. The research team found that the omega-3 fatty acid, docosahexaenoic acid, protects cells from this defect.
Dr Bazan's laboratory discovered earlier that neuroprotectin D1 (NPD1), a naturally-occurring molecule in the human brain that is derived from DHA, also promotes brain cell survival. In this system, NPD1 is capable of rescuing the dying cells with the pathological type of Ataxin-1, keeping their integrity intact.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze